iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.200
0.00 (0.00%)
Sep 15, 2026, 3:04 PM EDT - Market open
iBio, Inc. Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, iBio, Inc. stock has a consensus rating of "Strong Buy" and an average price target of $5.53. The average 1-year stock price forecast is 360.83% higher than the current stock price, while the lowest is $4.20 (+250.00%) and the highest is $7.00 (+483.33%).
Price Target: $5.53 (+360.83%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for iBio, Inc. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Initiates $6 | Buy | Initiates | $6 | +400.00% | Aug 31, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 | Buy | Maintains | $5 | +316.67% | Aug 28, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $5 | Buy | Reiterates | $5 | +316.67% | Jul 2, 2026 |
| Raymond James | Raymond James | Buy Initiates $5 | Buy | Initiates | $5 | +316.67% | Jun 8, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $5 → $6 | Buy | Maintains | $5 → $6 | +400.00% | May 15, 2026 |
Financial Forecast
Revenue This Year
28.57K
from 100.00K
Decreased by -71.43%
Revenue Next Year
25.00K
from 28.57K
Decreased by -12.50%
EPS This Year
-0.40
from -0.32
EPS Next Year
-0.61
from -0.40
EPS and Forward PE are based on non-GAAP adjusted numbers.